No products in the cart.
GMP-BioFcR-ag-015
$5,990.00 – $293,000.00
Human Fc gamma receptor IIC (FcγRIIC, CD32c, Q13) His+Avi (Biotinylated) is used to measure the affinity of antibodies for it. The Fc receptor binding assay (Competitive ELISA immunoassay, SRP assay or BLI assay) plays a vital role in the development of therapeutic antibodies.
GeneMedi provides Human Fc gamma receptor IIC (FcγRIIC, CD32c, Q13) His+Avi (Biotinylated). The receptor has been classified based on its affinity for IgG1, IgG2, IgG3, IgG4. The Fc receptor is expressed on many immune cells and binds to the specific immunoglobulin, then modulating the immune response.
| Products Name1 | GMP-BioFcR-ag-015-1:Human Fc gamma receptor IIC (FcγRIIC, CD32c, Q13) His+Avi |
|---|---|
| Products Name2 | GMP-BioFcR-ag-015-2:Human Fc gamma receptor IIC (FcγRIIC, CD32c, Q13) His+Avi (Biotinylated) |
| Isotype | Fc gamma receptor IIC (FcγRIIC, CD32c) |
| Receptor name | |
| Species | Human |
| Principal antibody ligand | IgG1, IgG2, IgG3, IgG4 |
| Major role | Activation |
| Effect following binding to antibody | ADCC, ADCP |
| WT/Mutation | WT |
| Mutant variants functions vs WT | N/A |
| Fc Modifications or Mutations (Reduced effector function) | LE (ADCC),LALA(ADCC, ADCP,),LALA-PG (ADCP),TM,DA (ADCC, ADCP),GRLR (ADCC), IgG2/G4, IgG2m4 (ADCC, ADCP),Gly237Ala (ADCP),Glu318Ala (ADCP), Glu233Pro |
| Fc Modifications or Mutations (Enhanced effector function) | IgG1/IgA2 (ADCC) |
| Application | Antibody Fc&Fc Receptor binding affinity assay (Competitive ELISA immunoassay, Biacore-based SRP assay or BLI assay) |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS, PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Related products
biologics
$780.00 – $7,800.00
biologics
$5,990.00 – $293,000.00
biologics
$5,990.00 – $293,000.00
biologics
$5,990.00 – $293,000.00
biologics
$5,990.00 – $293,000.00
biologics
$5,990.00 – $293,000.00
biologics
$5,990.00 – $293,000.00
biologics
$5,990.00 – $293,000.00
